Headline Roundup November 16
Study Suggests Hormone Therapy Regrets Are 'Rare' Among Trans Youth, Media Split on Its Credibility
Summary from the AllSides News Team
"Satisfaction with [hormone therapy] was high and regret and harm were rare," according to a controversial study on transgender and "gender diverse" minors that was published last week.
The Study: The study, which JAMA Pediatrics published on November 9, aimed to answer the question, "What degrees of satisfaction, regret, and harm are reported by transgender and gender-diverse [TGD] participants who initiated testosterone or estrogen therapy (i.e., hormone therapy [HT]) as youth?" The 376 respondents, who started hormone therapy at an average age of 16, "could complete the survey [collected from October 2023 to October 2025] from 1 month before to 6 months after the yearly anniversary of their initial assessment."
The Results: The results found "In this cohort study of 372 participants [four did not complete the regret scale] who received care at a single multidisciplinary clinic, satisfaction with HT was high and regret and harm were rare. Decisional regret was slightly higher among youths not currently receiving HT and those identifying on the nonbinary spectrum, but it remained low in absolute terms⦠360 participants (96.8%) endorsed that receiving HT was the right decision, 10 (2.7%) reported regret, and 7 (1.9%) reported perceived harm." It concluded, "Results provide support for existing standards of care rather than broad restrictions on youths' access to HT."

JAMA cited several limitations of the study, such as, "it did not examine satisfaction with the specific effects of HT," "several participants reported ambivalent feelings toward HT," and "additional research specific to TGD youth is needed." However, it did not address the 42.6% nonresponse rate.
RELATED: Decline in Trans Identification Among Youth: Culture Shift or Policy Symptom? | AllSides
Media Support: The Washington Post (Lean Left bias) covered the story first, reporting, "The rates of regret for back, knee and gastric bypass surgery, for instance, are all higher [than for HT]." The Post cited two similar studies out of England and Princeton University, as well as a doctor who supported JAMA's conclusions. It did not mention the nonresponse rate.
The outlet criticized, "Conservative leaders and activists have pointed to a handful of detransitioners as proof that young people with gender dysphoria will regret the interventions, but this new study is one of several that have found most people who transitioned as adolescents remain happy they did."
Several other outlets on the left, such as PinkNews (Left), echoed the Post's reporting and omitted the nonresponse rate as well.
RELATED: Examples of Media Bias and How to Spot Them | AllSides
Media Skepticism: National Review (Right) labeled the study as "flawed" in its headline. It stated that the nonresponse rate "raises questions about sweeping claims of minimal regret after adolescent hormone treatment." It emphasized the reports of inadequate preparation that "underscore the stakes of informed consent and rigorous scrutiny of treatment guidelines" and suggested "researchers acknowledged that because the research was conducted by workers from the facility providing the treatment, former hormone recipients might have felt discouraged from participating."
Townhall (Right) furthered criticism by highlighting the 51% of respondents lost to follow-up. It predicted, "This story and study will be used as proof that mutilating teens and pumping them full of puberty blockers and cross-sex hormones is fine." The outlet cited support for the study but framed it as a symptom of the Post's reporting and evidence of its prediction.
The Federalist (Right) cited two surveys that juxtapose JAMA's: "a 2022 study of 952 young patients in the U.S. military health system, found that nearly 30 percent had stopped hormones within four years⦠[another of] 100 detransitioners found that only 24 percent ever told their transgender intervention providers they had stopped, which is exactly why a facility surveying its own former patrons may never hear from the ones who walked away."
The outlet framed the Post's spin as deliberate, "to peddle" the study's conclusion. "The Post told readers that researchers 'surveyed 376' people. They didn't. They surveyed 698," the outlet highlighted. "And while the average time since beginning treatment was approximately five years, some had started as recently as 1.2 months before the survey." It criticized, "How much can we possibly know about long-term regret when some participants have barely begun treatment? And who conducted this research? Workers from the very facilities providing the treatment."
"None of this proves the missing participants regretted their decisions," it stated, "But it certainly raises questions about how confidently these findings can be applied."

Written by the AllSides staff (of humans). Learn more. Support our mission.
Featured Coverage of this Story
On Nov. 11, The Washington Post published an article titled "Most transgender people have no regrets years after hormone therapy, study says." According to the Post, nearly 97 percent of individuals who began taking opposite-sex hormones as youths believed they made the right decision. Only about 3 percent reported regret, and fewer than 2 percent reported harm. Sounds pretty convincing, doesn't it?
Not so much. The study, published in JAMA Pediatrics on Nov. 9, examined satisfaction and regret among individuals who began taking opposite-sex hormones in their youth. Researchers reported...

Kayla Bartkowski/Getty Images
Most transgender people who receive hormone therapy as teenagers do not regret it, according to a study published Monday in JAMA Pediatrics.
Researchers at University of Texas Southwestern Medical Center and other universities surveyed 376 transgender and gender-diverse people and found that five years after the initial treatment, 360, or nearly 97 percent, said starting hormone therapy was the right decision, and roughly 3 percent said they regretted taking the medication. Nearly 2 percent said they both regretted the transition and believe it harmed them. On average, the participants started...
A new study has found that regret among people who starting gender-affirming hormone therapy as a minor was rare, with 96.8% saying it was the right decision.
Published on 9 November, the peer-reviewed cohort study from JAMA Pediatrics examined satisfaction, regret and harm among people who began hormone therapy before the age of 18. Researchers analysed self-reported survey responses collected between 2023 and 2025 from a cohort of nearly 400 participants...
AllSides Picks
More News about LGBTQ Issues on AllSides
News from the Left
News from the Center
News from the Right
The Federalist
Just The News